详细信息
背景信息
What is this antibody validated in? Anti-VE Cadherin antibody [EPR18229] - Intercellular Junction Marker (ab205336) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in Mouse samples. What is the molecular weight of VE Cadherin? Anti-VE Cadherin [EPR18229] - Intercellular Junction Marker (ab205336) specifically detects a band for VE Cadherin (UniProt: P55284) at a molecular weight of 88kDa. Trusted by the scientific community Anti-VE Cadherin [EPR18229] - Intercellular Junction Marker (ab205336) was first used in a scientific publication in 2015 and has been cited over 40 times in peer-reviewed journals. Other related products We have a range of other formats of antibody clone [EPR18229] also available for your convenience: ab205336, Alexa Fluor® 647 - ab225442, Alexa Fluor® 488 - ab225443, Carrier free - ab232515, Carrier free - ab242594 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 20µl. Discover our selection of trial-size antibodies.
文献引用 (85)
NLRP3/GSDMD-dependent neutrophil extracellular traps exacerbate microglia-mediated neuroinflammation following traumatic brain injury.
NLRP3/GSDMD依赖性中性粒细胞胞外陷阱加剧创伤性脑损伤后小胶质细胞介导的神经炎症。
ESM1 drives cancer angiogenesis and bevacizumab resistance via trioleate synthesis.
ESM1 通过三油酸酯合成驱动癌症血管生成和贝伐单抗耐药性。
Recombinant BMP9 Reinforces Gut Vascular Barrier in Experimental Colitis
重组BMP9可增强实验性结肠炎中的肠道血管屏障
Elucidating the mechanism of traditional Chinese medicine formula (Yifei-sanjie Pill) in alleviating the chemobrain based on network pharmacology and experimental verification.
基于网络药理学和实验验证,阐明传统中药方剂(益肺三解丸)缓解化疗脑的机制。
Biosynthesized nanoparticles of Tibetan medicine mercuric sulfide preparation to promote endocytosis and realize drug crossing through blood brain barrier.
利用藏药硫化汞制剂的生物合成纳米颗粒促进内吞作用,实现药物穿过血脑屏障
Endothelial CLEC5A drives barrier dysfunction and vascular leakage responsible for lung injury in bacterial pneumonia and sepsis.
内皮细胞 CLEC5A 导致屏障功能障碍和血管渗漏,从而造成细菌性肺炎和败血症中的肺损伤
A novel immunocompetent transgenic mouse model of DHF reveals Syk-mediated Th2-polarized cytokine storm as a key driver of vascular leakage
一种新型的具有免疫功能的转基因小鼠登革出血热模型揭示了Syk介导的Th2极化细胞因子风暴是血管渗漏的关键驱动因素。
Gingival Soft Tissue Integrative Zirconia Abutments with High Fracture Toughness and Low-Temperature Degradation Resistance
具有高断裂韧性和抗低温降解性的牙龈软组织一体化氧化锆基台
Activation of angiopoietin-1 signaling with engineering mesenchymal stem cells promoted efficient angiogenesis in diabetic wound healing
利用工程间充质干细胞激活血管生成素-1信号,促进糖尿病伤口愈合中的有效血管生成
Adrenomedullin 2 attenuates anxiety-like behaviors by increasing IGF-II in amygdala and re-establishing blood-brain barrier
肾上腺髓质素 2 通过增加杏仁核中的 IGF-II 和重建血脑屏障来减轻焦虑样行为
- 1
- 2
- 3
- 4
- 5
- 6
- 9